Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0088
0.00 (0.00%)
Apr 1, 2025, 3:12 PM EST
Evofem Biosciences Employees
Evofem Biosciences had 32 employees as of December 31, 2024. The number of employees decreased by 6 or -15.79% compared to the previous year.
Employees
32
Change (1Y)
-6
Growth (1Y)
-15.79%
Revenue / Employee
$605,094
Profits / Employee
-$280,156
Market Cap
1.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 116 |
| American Oncology Network | 1,525 |
Evofem Biosciences News
- 6 days ago - Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics - PRNewsWire
- 8 days ago - Evofem Reports Fourth Consecutive Year of Net Sales Growth - PRNewsWire
- 12 days ago - Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product - GlobeNewsWire
- 6 weeks ago - Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO - PRNewsWire
- 4 months ago - Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 - PRNewsWire
- 5 months ago - Evofem Secures Investor Support for Proposed Merger through Voting Agreements - PRNewsWire
- 8 months ago - Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution - PRNewsWire
- 8 months ago - Evofem Biosciences GAAP EPS of $0.00, revenue of $4.16M - Seeking Alpha